Overview
- CXMT’s Shanghai STAR Market listing on July 27 raised about ¥57.9 billion (roughly $8.6 billion) and sent the stock sharply higher, giving the company large new capital for fabs and R&D.
- Industry reports say a CXMT affiliate has reached the tail end of LPDDR6 research-and-development validation, a required step before small-batch test runs and eventual mass production.
- The company is in early-stage talks to build a second 12-inch DRAM plant in Beijing’s Yizhuang and is discussing funding with local government-backed investment vehicles.
- Regulatory and political obstacles remain significant because U.S. export controls bar access to advanced EUV tools and the Pentagon has placed CXMT on a military-affiliated roster that has prompted U.S. lawmakers to warn buyers such as Apple.
- Analysts are split: some see Beijing-backed capital and fast capacity gains pushing down mobile and commodity DRAM prices, while others warn CXMT still lacks top-end tooling, strong yields, and clear customer qualification for immediate global displacement.